• 제목/요약/키워드: Epidermal growth factor(EGF)

검색결과 269건 처리시간 0.025초

임신부 뇨로부터 정제된 인간 상피세포 증식 인자 유사체의 in vitro bioassay 및 특성

  • 박세철;전재현;남정현;권태종;고인영;유광현
    • 한국미생물·생명공학회지
    • /
    • 제24권4호
    • /
    • pp.472-477
    • /
    • 1996
  • Natural human epidermal growth factor (nhEGF) was purified from pregnant human urine by benzoic acid adsorption, DEAE-Sepharose ion exchange, and immunoaffinity chromatography. The purified nhEGF was further separated into four fractions using Bondapak C$_{18}$ HPLC system. Following characterization by Western blot analysis and double immu- nodiffusion, we found that each fraction corresponds to four derivatives of the nhEGF. For biological analysis of nhEGF, we optimized the labeling time and serum concentration for the incorporatioin of 5-bromo-2'-deoxy uridine (BrdU), a non-radioactive alternative for [$^{3}$H]-thymidine uptake, into NIH 3T3 cells. The DNA synthesis of NIH 3T3 cells was gradually increased at the nhEGF concentrations between 0.1 - 10 ng/ml in the Dulbecco's Modified Eagles Medium (DMEM) containing 0.2% Fetal calf serum (FCS). When we assayed the biological activity of four fractions, the activity of the second fraction was superior to that of the others. Based on the results from the HPLC analysis spiked with recombinant human epidermal growth factor (rhEGF) and amino acid sequencing, we concluded that the second fraction was nhEGF and the other three fractions were the derivatives of nhEGF. In addition, the proportion of nhEGF was approximately 46% is compared with that of the other three derivatives.

  • PDF

상피세포성장인자를 함유한 동결건조-재분산 리포좀의 입도분포 및 봉입률 (Size Distribution Characteristics and Entrapment Efficiency of Dried-Reconstituted Liposomes Containing Epidermal Growth Factor)

  • 김희준;유성운;최영욱
    • 약학회지
    • /
    • 제40권6호
    • /
    • pp.646-652
    • /
    • 1996
  • Epidermal Growth Factor (EGF), discovered by Stanley Cohen in 1960, has a potential healing effect for wounds and bums. Considering wound care, in order to avoid physical stress at the wound surface and efficiently apply EGF, the need for viscous spraying solutions was essential. Viscous spraying solutions containing EGF were prepared by utilizing viscosity-building polymer, poloxamer 407, and by introducing liposome systems. On the other hand, EGF is purified on reverse HPLC gradient program with the mobile solvent of acetonitrile. It is necessary to observe liposomal EGF changes as the acetonitrile contents varied in order to introduce liposome systems at the step of EGF solution (at the time of EGF purifying). By evaluating the size distribution and entrapment efficiency of EGF liposome, it was possible to detemine the limit contents of acetonitrile and establish the optimal conditions for solution formulations. It has been revealed that, as the acetonitrile content increases, mean diameter of EGF liposomes increased and the width of size distribution tends to decrease. The limit contents of acetonitrile were 10%, since there was little difference to the acetonitrile free liposomes.

  • PDF

Escherichia coli에서 발현된 재조합 인간 상피세포 증식인자의 정제 및 특성

  • 박세철;유광현
    • 한국미생물·생명공학회지
    • /
    • 제24권4호
    • /
    • pp.478-484
    • /
    • 1996
  • Recombinant human epidermal growth factor (rhEGF) was produced by E. coli BL21 harboring a plasmid pYHB101. The maximum production was 68.7 mg/l when the E. coli strain was cultured at 25$\circ$C for 48 hours in the modified MBL medium containing 10 g/l glucose with 1 mM IPTG induction at 2 hours after inoculation. The rhEGF was purified upto 267 folds by Amberlite XAD- 7 chromatography, ultrafiltration, and DEAE Sepharose fast flow ion exchange chromatography with an overall yield of 66.6%. The purified rhEGF was further separated into two fractions by HPLC. The N-terminal amino acid sequence of the second fraction was Asn-Ser-Asp-Ser-Glu-Cys-Pro-Leu-Ser-His. The effect of rhEGF on the DNA synthesis was examined using in vitro biological assay based on the incorporation of 5'-bromo-2'- deoxy-uridine (BrdU). The purified rhEGF shows no difference with natural human epidermal growth factor (nhEGF) in N-terminal amino acids residues and biological activity. From the results, we concluded that rhEGF produced from E. coli harboring the plasmid pYHB101 was apparently the same as nhEGF.

  • PDF

Translocation of Annexin I to the Nucleus by Epidermal Growth Factor in A549 Cells

  • Rhee, Hae-Jin;Kim, Seung-Wook;Soo-Ok, Lee;Park, Young-Min;Na, Doe-Sun
    • BMB Reports
    • /
    • 제32권1호
    • /
    • pp.28-32
    • /
    • 1999
  • Annexin I (also called lipocortin 1), a 37-kDa member of the annexin family of proteins, has been implicated in the mitogenic signal transduction by epidermal growth factor (EGF). Annexin I is phosphorylated by the EGF signal, however, the role of annexin I in the EGF signal transduction is still unknown. To transduce extracellular signals into the intracellular targets, selective translocation of the signaling molecules to their targets would be necessary. In this study, we examined the subcellular locations of annexin I during EGF signal transduction. Treatment of A549 cells with EGF resulted in the translocation of cytoplasmic annexin I to the nucleus and perinuclear region as determined by Western blot and immunofluorescent staining. The nuclear translocation of annexin I was inhibited by tyrphostin AG 1478 and genistein, the inhibitors of EGF receptor kinase and downstream tyrosine kineses, respectively. Pretreatment of cells with cyclohexamide did not inhibit the nuclear translocation. The results suggest that nuclear translocation of annexin I is controlled by a series of kinase dependent events in the EGF receptor signaling pathway and may be important in tranducing the signals by EGF.

  • PDF

치주인대세포 및 치은섬유아세포의 증식능에 대한 Epidermal growth factor의 영향 (The Effect of EGF on Proliferation Rate of the Human Periodontal Ligament Cells and Human Gingival Fibroblasts)

  • 김선우;이재목;서조영
    • Journal of Periodontal and Implant Science
    • /
    • 제26권4호
    • /
    • pp.841-858
    • /
    • 1996
  • Epidermal growth factor(EGF) is one of polypeptide growth factors. EGF has been reported as a biological mediator which regulates activities of wound healing process including the cell proliferation, migration and metabolism. The purposes of this study is to evaluate the effects of EGF on the human periodontal ligament cells and human gingival fibroblast cells that promote regeneration of periodntal tissue. The mitogenic effects of epidermal growth factor on human periodontal ligament cells and human gingival fibroblasts were evaluated by determining the incorporation of 5-Bromo-2'-deoxy-uridine into DNA of the cells in a dose dependent manner. The prepared cells were the primary cultured gingival fibroblast and periodontal ligament cells from humans, the fourth or sixth subpassages were used in the experiments. Cells were seeded in DMEM containing 10% FBS. 1, 10, 50, 100, $200{\eta}g/ml$ and epidermal growth factor were added to the quiescent cells for 24 hours, 48 hours and 72 hours. They were labeled with $10\{mu}l/200{\mu}l$ 5-Bromo-2'-deoxy-uridine for the last 6 hours of each culture. The results of the five determinants were presented as mean and S.D.. The results were as follows : The DNA synthetic activity of human gingival fibroblasts were increased dose dependently by epidermal growth factor at 24 hours, 48 hours and 72 hours. The mitogenic effects were similar at the 24 and 48 hours of epidermal growth factor, but the DNA synthetic activity of human gingival fibroblasts generally decreased at 72 hours. The DNA synthetic activity of human periodontal ligament cells were increased dose dependently by epidermal growth factor at 24 hours but the DNA synthetic activity decreased at $200{\eta}g/ml$ of each hour. Generally the maximum mitogenic effects were observed at the 48 hours application of epidermal growth factor. The DNA synthetic activity of human periodontal ligament cells generally decreased lower at 24, 72 hours than at 48 hours the application of epidermal growth factor. In the comparison of DNA synthetic activity between human gingival fibroblasts and human periodontal ligament cells, human periodontal ligament cells had slightly higher proliferation activity than human gingival fibroblasts for a longer time at the high dosage of the epidermal growth factor. In conclusion, epidermal growth factor have important roles in the stimulation of DNA synthesis in human periodontal ligament cells and human gingival fibroblasts, and thus may be useful for clinical applications in periodontal regenerative procedures.

  • PDF

Epidermal Growth Factor가 돼지 미성숙난포란의 체외성숙에 미치는 영향 III. 체외 수정에 미치는 Epidermal Grwoth Factor의 효과 (Effect of Epidermal Growth Factor on In Vitro Maturation in Pig Immature Oocytes III. Effect of Epidermal Growth Factor on In Vitro Fertilization)

  • 엄상준;김은영;김묘경;추영국;윤산현;박세필;정길생;임진호
    • 한국가축번식학회지
    • /
    • 제20권2호
    • /
    • pp.127-134
    • /
    • 1996
  • 본 연구는 epidermal growth factor(EGF)가 처리된 돼지 체외성숙란의 수정능력을 조사하기 위하여 실시하였다. 돼지 미성숙란의 성숙을 위해서 배양액내에 EGF(10ng/ml)와 FSH(10$\mu\textrm{g}$/ml) 또는 FBS(10%)를 단독 혹은 공동 첨가함으로서 4처리군으로 처리하였다(1:무처리군, 2:EGF 단독 처리군, 3: FSH와 FBS 공동 처리군, 4: EGF와 FSH 그리고 FBS 공동 처리군). 그 결과 2, 3, 4 처리군의 핵성숙율은 무처리군보다 현저하게 높았다(P<0.001). 수정율에 있어서 EGF 단독 처리군의 경우 3과 4 처리군보다 낮았지만, 무처리군보다는 현저하게 높았다(P<0.05). 더욱이 EGF와 FSH 그리고 FBS의 공동 처리군의 경우 다른 모든 처리군에 비하여 정자 침입뿐만 아니라 웅성 전핵 형성율이 높았다(P<0.05). 따라서 돼지 난포란의 체외성숙시 EGF 단독 처리만으로는 핵성숙에 수반된 세포질 성숙률은 낮았지만, EGF와 FSH 및 FBS를 공동 처리했을 때 돼지 체외성숙란의 세포질 성숙도 효과적으로 유도된다는 것을 알 수 있다.

  • PDF

Epidermal Growth Factor가 돼지 미성숙난포란의 체외성숙에 미치는 영향 I. 핵성숙에 미치는 Epidermal Growth Factor의 효과 (Effect of Epidermal Growth Factor on In Vitro Maturation in Pig Immature Oocytes I. Effect of Epidermal Growth Factor in Nuclear Maturation)

  • 엄상준;김선의;김은영;윤산현;박세필;정길생;임진호
    • 한국가축번식학회지
    • /
    • 제19권3호
    • /
    • pp.217-226
    • /
    • 1995
  • 본 연구는 돼지 미성숙난포란의 체외배양시 핵성숙에 미치는 EGF의 효과를 검토하고자 실시하였다. 기초 배양액으로는 TCM-199에 0.2mM pyruvate, 1$\mu\textrm{g}$/ml estradiol-17$\beta$, 25$\mu\textrm{g}$/ml gentamycin을 첨가하였으며, 이 배양액에 EGF, FSH와 FBS을 처리하였다. 실험 1에서는 난포란 성숙에 있어서 FSH와 0, 10, 100 ng EGF/ml의 농도에 따른 효과를 조사하였던 바, 1, 10, 100 ng EGF/ml가 처리된 군의 핵성숙율은 83.0, 86.7, 87.5%로서 무처리군 27.3%와 FSH 처리군 60.3%보다 유의하게 높았다(p<0.001). 실험 2에서는 EGF, FSH와 FBS의 상호작용에 대해서 조사하였다. EGF 단독, EGF에 FSH 첨가, EGF에 FBS 첨가, FSH에 FBS 첨가와 EGF와 FSH에 FBS가 첨가된 군의 핵성숙율은 86.7, 90.2, 87.1, 89.6, 92.6%로서 무처리 군 22.3%, FSH와 FBS가 각각 단독 처리된 군의 52.2, 42.3%보다 유의하게 높았다(p<0.001). 또한, 정상적인 난구세포의 팽창은 FSH에 FBS, FSH에 EGF 혹은 FSH, EGF와 FBS가 첨가된 군에서 나타났으며, EGF가 첨가된 군에서는 대부분의 난구세포가 난포란으로부터 분리되었지만, 일부는 덩어리로 난포란에 부착되어 있었다. 따라서, EGF는 돼지 미성숙난포란에 있어서 핵성숙을 유도할 수 있다고 사료된다.

  • PDF

폐암에서 Epidermal growth factor와 Tumor Necrosis Factor-$\alpha$의 발현 (Expression of the Epidermal Growth Factor and Tumor Necrosis Factor-$\alpha$ in Lung Cancer)

  • 장덕기;이충석;박성달;김송명
    • Journal of Chest Surgery
    • /
    • 제34권2호
    • /
    • pp.138-147
    • /
    • 2001
  • 배경: 폐암발생에 EGF의 자가 분비는 암의 성장과정에 직, 간접적인 영향을 주고 있으며, TNF-$\alpha$는 면역 반응의 급성체로서 폐암의 발생을 억제하고 이미 발생한 폐암종의 치료에도 이용되고 있는 실정이다. 폐암 조직과 혈장에서 epidermal growth factor(EGF)와 tumor necrosis factor-$\alpha$(TNF-$\alpha$)를 면역 방사선 분석법을 이용하여 정량분석 하여 발현 정도를 분석해보고자 하였다. 대상 및 방법: 폐암환자 20례와 양성종양 및 육아종 환자 4례에 대해서 AJCCS에 의한 조직학적 분류와 TNM 분류에 따라 구분하여 절제수술을 받은 환자를 대상으로 수술전 혈액을 채취하고 수술직후 적출한 표본을 암이 없는 건강하다고 판단되는 대조조직과 폐암조직에서 일정량의 조직을 절취하여 액화질소 내에 실험시까지 급속 냉동보관 하였다. 수술후 혈액을 재 채취하여 혈장을 분리하여 냉동고에 검사시까지 보관하였다. EGF의 정량은 Human Epidermal Growth Factor kit(Amersham Phamacia Biotech, England)를 사용하였으며, TNF-$\alpha$ 정량은 TNF-$\alpha$ IRMA kit(Biosouce, Belgium)을 사용하여 IRMA 방법으로 각각 정량분석하여 표현유무를 연구한 결과 다음과 같은 결론을 얻었다. 결과: 1. 대조조직, 양성종양 및 육아종과 폐암 수술전후의 조직과 혈청 모두에서 EGF와 TNF-$\alpha$가 발현되었다. 2. EGF와 TNF-$\alpha$의 농도는 대조조직과 양성종양(0.11$\pm$0.06 ng/ml, 20,3$\pm$9.08 pg/ml)에 비하여 폐암조직(0.13$\pm$0.05 ng/ml, 34.34$\pm$47.74pg/ml)에서 유의하게 높은 농도가 발현되고 있었다. 3. 폐암중 선암조직에서 특히 TNF-$\alpha$(80.92$\pm$104.08 ng/ml)의 발현이 강하게 나타났다. 4. 혈청내의 EGF와 TNF-$\alpha$의 발현되는 양이 조직내의 양보다도 높았다. EGF는 5.7배정도 TNF는 1.3배정도 강하게 표현되었다. 5. 폐암의 조직학적 종류에 따라서 EGF는 거의 차이가 없었으나 TNF-$\alpha$ 정량치에는 차이가 있었다. 6. TNM stage가 진행함에 따라 EGF는 농도가 증가하였고 TNF-$\alpha$는 오히려 감소하는 반대되는 교차현상이 있었다. 7. 수술직후 EGF는 증가하였으나 TNF-$\alpha$는 오히려 감소하였다. 결론: 결론적으로 저자는 암조직과 대조조직간에 EGF와 TNF-$\alpha$의 표현량의 차이가 있음을 관찰하였으며 또한 조직과 혈청사이에도 표현량에 차이가 있으며 조직보다도 오히려 혈청내의 농도가 높다는 사실을 관찰하였다. EFG와 TNF-$\alpha$는 정상조직이나 양성조직과 폐암조직 모두에서 분비작용되는 cytokines으로 세포기능에 따라 다양하게 표현이 되며 계속적인 연구로서 밝혀야만 할 과제라고 판단된다.

  • PDF

생쥐 선상칼리크레인(상피세포증식인자 결합단백질 Type A, B, 그리고 C)의 Ren 2 Prorenin에 대한 기질특이성 (Substrate Specificity of Mouse Glandular Kallikreins, Epidermal Growth Factor-Binding Protein Type A, B, and c against Mouse Ren 2 Prorenin)

  • 김화선;이희섭전병훈김원신
    • 한국동물학회지
    • /
    • 제39권2호
    • /
    • pp.215-222
    • /
    • 1996
  • In the previous studies, we have demonstrated that prorenin converting enzyme (PRECE) was identical to the epidermal grouch factor-binding protein (EGF-BP) type B, which was a member of the mouse glandular kallikrein family, To examine whether or not EGF-BP type A and C are involved in the processing of prorenin, we have cloned the CDNAS of the EGF-BP type h and C from a library of male ICR mouse submandibular gland (SMGI. And then CHO cells were transfected with the EGF-BP expression plasmids. and stable cell lines expressing a high level of the EGF-BPS precursor were obtained. The conditioned medium was then treated with trypsin, which has been knotvn to effectively convert the EGF-BP type A and C precursor to the active forms. 수ubsequentlv, the prorenin converting activity of the trypsin-treated or untreated medium was examined. PRECE converted exactly prorenin to renin, but the prorenin converting activities of EGF-BP type A and C were not detected. From these results, it seems that only type B of these EGF-BPs is involved in processing Ren 2 prorenin in mouse SMG.

  • PDF

Determination of Recombinant Human Epidermal Growth factor (rhEGF) in a Pharmaceutical Formulation by High Performance Liquid Chromatography with Electrochemical Detection

  • Lee, Kang-Woo;Hwang, Kyung-Hwa;Kim, Chang-Soo;Han, Kun;Chung, Youn-Bok;Park, Jeong-Sook;Lee, Yong-Moon;Moon, Dong-Cheul
    • Archives of Pharmacal Research
    • /
    • 제24권4호
    • /
    • pp.355-359
    • /
    • 2001
  • A novel HPLC method with electrochemical detection has been developed for the determination of recombinant human epidermal growth factor (rhEGF) in pharmaceutical products. rhEGF was separated from other components in formulation on a reversed-phase C18 column with 24% acetonitrile in 0.1 M phosphate buffer (pH 4.75). The optimum electrochemical oxidation of EGF was obtained at 0.85 V vs. Ag/AgCl in a glassy carbon working electrode due to electroactive tyrosine, tryptophan, methionine, and arginine residues. The quantitation range was from 1.0 to 200 ng of rhEGF with the linear correlation coefficient greater than 0.999. The method was successfully applied for the quantitation of rhEGF in a pharmaceutical preparation.

  • PDF